Anti-Angiogenic Drugs for Second-Line Treatment of NSCLC Patients: Just New Pawns on the Chessboard?

Expert Opinion on Biological Therapy - United Kingdom
doi 10.1517/14712598.2015.1075000
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

Systemic Treatment in EGFR-ALK NSCLC Patients: Second Line Therapy and Beyond

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Efficacy of Continuing Anti-Angiogenic Agents in the Second-Line Treatment for Metastatic Colon Cancer Depending on the KRAS Mutation Status: A Meta-Analysis

Colorectal Oncology
2018English

Use and Abuse of Anti-Angiogenic Drugs for Retinopathy of Prematurity Treatment in Argentina, 2015

Archivos Argentinos de Pediatria
Child HealthPediatricsPerinatology
2016English

P3.01-110 Defining Aggressive Disease in Patients With Advanced NSCLC Receiving Second-Line Treatment: A Systematic Review

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Second Opinion From Observational Data on Second-Line Diabetes Drugs

JAMA network open
Medicine
2018English

The Diagnostic Accuracy of the GenoType®MTBDRslassay for the Detection of Resistance to Second-Line Anti-Tuberculosis Drugs

2014English

A Study to Detect Liver Enzyme Dysfunction Among Patients on First Line Anti-Tubercular Drugs From RNTCP During the Course of Anti-Tb Treatment

Journal of Evolution of Medical and Dental Sciences
2020English

A Quantitative Microfluidic Angiogenesis Screen for Studying Anti-Angiogenic Therapeutic Drugs

Lab on a Chip - Miniaturisation for Chemistry and Biology
BiochemistryNanoscienceBioengineeringNanotechnologyChemistryBiomedical Engineering
2015English

Adverse Drug Reactions in Patients on Second Line Anti-Tubercular Drugs for Drug Resistant Tuberculosis in Rural Tertiary Care Hospital in North India

Journal of Tuberculosis Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy